Does ALISKIREN Cause Bladder transitional cell carcinoma? 22 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Bladder transitional cell carcinoma have been filed in association with ALISKIREN. This represents 1.4% of all adverse event reports for ALISKIREN.
22
Reports of Bladder transitional cell carcinoma with ALISKIREN
1.4%
of all ALISKIREN reports
0
Deaths
22
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From ALISKIREN?
Of the 22 reports, 22 (100.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALISKIREN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does ALISKIREN Cause?
Fall (341)
Asthenia (333)
Blood pressure increased (303)
Nausea (293)
Headache (271)
Malaise (268)
Vomiting (240)
Cough (237)
Fatigue (236)
Pyrexia (234)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which ALISKIREN Alternatives Have Lower Bladder transitional cell carcinoma Risk?
ALISKIREN vs ALISKIREN HEMIFUMARATE
ALISKIREN vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALISKIREN vs ALIZAPRIDE
ALISKIREN vs ALLANTOIN
ALISKIREN vs ALLEGRA